Published online June 29, 2009
PEDIATRICS Vol. 124 No. 1 July 2009, pp. 65-70 (doi:10.1542/peds.2008-3388)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Stecher, D.
Right arrow Articles by Keahey, L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stecher, D.
Right arrow Articles by Keahey, L.
Related Collections
Right arrow Emergency Medicine
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Epinephrine Auto-injectors: Is Needle Length Adequate for Delivery of Epinephrine Intramuscularly?

Dawn Stecher, MDa, Blake Bulloch, MDa, Justin Sales, MDa, Carrie Schaefer, MDb and Laine Keahey, MDc

a Departments of Emergency Medicine
b Radiology
c Allergy, Phoenix Children's Hospital, Phoenix, Arizona

OBJECTIVE: Studies show that intramuscular epinephrine results in peak plasma concentrations of epinephrine faster than the subcutaneous route, and therefore, epinephrine is recommended to be administered intramuscularly. The objective of this study was to determine if the needle length on epinephrine auto-injectors is adequate to deliver epinephrine intramuscularly in children.

METHODS: Patients between the ages of 1 and 12 years who presented to a children's hospital were enrolled in the study. Ultrasound was used to determine the depth from the skin to the vastus lateralis muscle. The patient's body mass index was recorded. The data were analyzed using simple descriptive statistics, and logistic regression was used to identify variables that might predict whether or not the needle length was exceeded.

RESULTS: A total of 256 children were enrolled. Of these, 158 children weighed less than 30 kilograms and would be prescribed the 0.15mg epinephrine auto-injector. Nineteen of these children (12%) had a skin to muscle surface distance of >1/2'' and would not receive epinephrine intramuscularly from current auto-injectors. There were 98 children weighing ≥30 kilograms who would receive the 0.3 mg epinephrine auto-injector. Of these 98 children, a total of 29 (30%) had a skin to muscle surface distance of >5/8'' and would not receive epinephrine intramuscularly.

CONCLUSION: The needle on epinephrine auto-injectors is not long enough to reach the muscle in a significant number of children. Increasing the needle length on the auto-injectors would increase the likelihood that more children receive epinephrine by the recommended intramuscular route.

Key Words: anaphylaxis • epinephrine • epinephrine auto-injector • allergic reaction

Abbreviations: CI—confidence interval • ED—emergency department • CT—computed tomography

Accepted Jan 29, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 AAP NewsHome page
C. Kemp
Needle length inadequate on epinephrine auto-injectors
AAP News, September 1, 2009; 30(9): 2 - 2.
[Full Text] [PDF]

eLetters:

Read all eLetters

Uncertain benefit and potential risk of longer needles for epinephrine auto-injectors
Jeffrey Miller
Pediatrics Online, 20 Aug 2009 [Full text]